InvestorsHub Logo
Followers 46
Posts 1362
Boards Moderated 0
Alias Born 08/09/2015

Re: None

Saturday, 03/06/2021 5:11:19 PM

Saturday, March 06, 2021 5:11:19 PM

Post# of 462047
Cassava Sciences Can Get To Market Early In Alzheimer's
Joe Springer

https://seekingalpha.com/article/4411393-cassava-sciences-early-to-alzheimers-market?mail_subject=sava-cassava-sciences-can-get-to-market-early-in-alzheimer-s&utm_campaign=rta-stock-article&utm_content=link-0&utm_medium=email&utm_source=seeking_alpha

Note: I am behind in my reading and posting. It could be that someone posted this the other day. I do not know, but it would be interesting if someone has done an in-depth comparison of Simufilam (Cassava’s drug and AVXL 2-73).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News